PPA
RYTM icon

Parametric Portfolio Associates’s Rhythm Pharmaceuticals RYTM Stock Holding History

Parametric Portfolio Associates’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$119K Sell
10,309
-5,881
-36% -$51.6K ﹤0.01% 3535
2021
Q4 		$162K Sell
16,190
-2,660
-14% -$29.9K ﹤0.01% 3462
2021
Q3 		$246K Sell
18,850
-6,405
-25% -$97.8K ﹤0.01% 3370
2021
Q2 		$494K Sell
25,255
-17,300
-41% -$359K ﹤0.01% 3088
2021
Q1 		$905K Buy
42,555
+8,679
+26% +$252K ﹤0.01% 3210
2020
Q4 		$1.01M Sell
33,876
-12,551
-27% -$319K ﹤0.01% 3050
2020
Q3 		$1.01M Buy
46,427
+11,242
+32% +$258K ﹤0.01% 2915
2020
Q2 		$785K Buy
35,185
+4,923
+16% +$96K ﹤0.01% 3051
2020
Q1 		$461K Buy
+30,262
New +$542K ﹤0.01% 3203
2019
Q4 		– Sell
-29,117
Closed -$629K – 3993
2019
Q3 		$629K Sell
29,117
-100
-0.3% -$2.15K ﹤0.01% 3250
2019
Q2 		$643K Buy
29,217
+5,788
+25% +$146K ﹤0.01% 3264
2019
Q1 		$642K Sell
23,429
-5,770
-20% -$166K ﹤0.01% 3224
2018
Q4 		$785K Sell
29,199
-4,746
-14% -$131K ﹤0.01% 3107
2018
Q3 		$990K Buy
33,945
+6,218
+22% +$196K ﹤0.01% 3102
2018
Q2 		$867K Buy
27,727
+7,010
+34% +$192K ﹤0.01% 3123
2018
Q1 		$412K Buy
20,717
+40
+0.2% +$1.06K ﹤0.01% 3438
2017
Q4 		$601K Buy
+20,677
New +$547K ﹤0.01% 3250

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Parametric Portfolio Associates's RYTM Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Rhythm Pharmaceuticals (RYTM) stake by 36% in Q1 2022, selling an estimated $51.6K and leaving 10,309 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #3535.

Parametric Portfolio Associates first reported a position in RYTM in Q4 2017 and has held it in 17 quarters since. The position peaked at $1.01M in Q4 2020. 111 funds tracked by Wall St. Rank hold RYTM as of Q1 2022.

  • Parametric Portfolio Associates held 10,309 shares of Rhythm Pharmaceuticals worth $119K as of Q1 2022.
  • Parametric Portfolio Associates sold 5,881 Rhythm Pharmaceuticals shares in Q1 2022, an estimated $51.6K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3535 holding.
  • Parametric Portfolio Associates first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 17 quarters since.
  • Parametric Portfolio Associates's Rhythm Pharmaceuticals position peaked at $1.01M in Q4 2020.
  • 111 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.